中西医结合治疗原发性心脏血管肉瘤伴肺转移临床报道  

Clinical report of the integrative medicine in the treatment of primary cardiac angiosarcoma with lung metastasis

作　　者：李娜[1] 杨松梅 熊燕[1] 何俊安 张洪[1,2] LI Na;YANG Songmei;XIONG Yan;HE Jun’an;ZHANG Hong

机构地区：[1]成都中医药大学附属眉山医院/眉山市中医医院,四川眉山620010 [2]四川省名中医何俊安传承工作室,四川眉山620010

出　　处：《中医临床研究》2024年第24期57-61,共5页Clinical Journal Of Chinese Medicine

基　　金：眉山市科学技术局科研项目(KJZD202236);国家中医药管理局第七批全国老中医药专家学术经验继承项目(国中医药人教函〔2022〕76号)。

摘　　要：原发性心脏血管肉瘤是罕见的起源于血管内皮细胞的软组织肉瘤,早期患者症状无特异性,病情进展迅速,转移征象是大多数患者最初就诊的原因,很大一部分患者就诊的原因为肺转移造成的咯血征象。该病无标准治疗方案,明确诊断时多数已处于晚期,预后差,可采取中西医结合治疗方法以延长患者的生存时间,提高其生命质量。Primary cardiac angiosarcoma is a rare soft tissue sarcoma originating from vascular endothelial cells.The symptoms of early patients are non-specific,and the disease progresses rapidly.Signs of metastasis are the initial reason for most patients to seek medical treatment,and the reason for most patients to seek medical treatment is hemoptysis caused by lung metastasis.There is no clear standard treatment for the disease,and most of the patients are diagnosed at advanced stage,and the prognosis is poor.The integrative medicine can be adopted for such patients to prolong their survival time and improve their quality of life.

关 键 词：原发性心脏血管肉瘤 咯血 中西医结合治疗 

分 类 号：R273[医药卫生—中西医结合]